Women with germline BRCA1 or BRCA2 mutations are recommended to undergo prophylactic bilateral salpingo-oophorectomy (RRSO) to reduce their risk of developing ovarian cancer (and breast cancer), usually by age 40 or after the completion of childbearing [44]. This evidence concerns the gene BRCA2 and ovarian cancer.